top of page

SynaptixBio contributes to PharmaSources analysis of antisense technology

Mar 22, 2025

1 min read

Read SynaptixBio's analysis of antisense in PharmaSources article here : Making Sense of Antisense: The Power of Gene Silencing - PharmaSources.com

SynaptixBio contributes to PharmaSources analysis of antisense technology

Recent Posts

Drug Target Review features an insightful article by Dan Williams that explores the extraordinary achievements of AI in drug design

Drug Target Review features an insightful article by Dan Williams that explores the extraordinary achievements of AI in drug design

Dr Uwe Meya, SynaptixBio’s CMO

Technology Networks features a major interview with Dr Uwe Meya, SynaptixBio’s CMO, in which the issues around organising, funding, and conducting clinical trials for rare diseases are discussed.

Dan Williams contributes to a major article for Inside Precision Medicine, in which several US families with a child living with H-ABC discuss their journey to a diagnosis

Dan Williams contributes to a major article for Inside Precision Medicine, in which several US families with a child living with H-ABC discuss their journey to a diagnosis

Comments

Commenting on this post isn't available anymore. Contact the site owner for more info.

bottom of page